[Oculogenital Chlamydia trachomatis infections in adults].
The aim of the research was to determine the prevalence of C. trachomatis (C.t.) conjunctivitis and urogenital infections coexistence in adults. The study was carried out on 222 patients (109 women and 113 men) with clinical signs of conjunctivitis. Conjunctival swabs were taken from all patients for evaluation and urogenital swabs as well as blood from the patients with confirmed infection. Direct diagnostics of chlamydial infections involved IF and LCR methods while serologic diagnostics (specific IgG antibodies) used EIA and indirect IF methods. The control group for conjunctival swabs included 52 volunteers who did not have any ophthalmological symptoms while for the serological tests the control group consisted of 103 blood donors. Ocular C.t. infection was diagnosed in 42 out of 222 (18.9%) patients with conjunctivitis symptoms and in 2 out of 52 (3.8%) patients of the control group. Chlamydial conjunctivitis was mostly (70%) found in young people (18-30 yrs) and it was twice more common in women. It was usually bilateral and chronic. Urogenital C.t. infection was diagnosed in 24 out of 42 (57.1%) patients and it was more common in men (14 patients) than in women (10 patients). Only 4 out of 42 (9.5%) patients suffered from any urogenital symptoms. Specific IgG antibodies were found in the serum of 29 out of 42 (69%) patients with chlamydial conjunctivitis and only in 6 out of 103 (5.8%) patients of the control group. The diagnostics of the ocular infections, which are resistant to routine treatment, should involve the consideration of etiological role of C.t. Due to common urogenital chlamydial infection coexistence both sexual partners should be diagnosed and treated.
Ostaszewska-Puchalska
Iwona
I
Ośrodka Diagnostyczno-Badawczego Chorób Przenoszonych Droga Płciowa w Białymstoku. centstd@poczta.onet.pl
Zdrodowska-Stefanow
Bozena
B
Puciło
Katarzyna
K
D000328:Adult; D000368:Aged; D002690:Chlamydia Infections / Q000453:epidemiology* / Q000382:microbiology*; D002692:Chlamydia trachomatis / Q000276:immunology / Q000302:isolation & purification; D005260:Female; D052776:Female Urogenital Diseases / Q000453:epidemiology* / Q000382:microbiology*; D005831:Genital Diseases, Female / Q000453:epidemiology / Q000382:microbiology; D005832:Genital Diseases, Male / Q000453:epidemiology / Q000382:microbiology; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D008297:Male; D052801:Male Urogenital Diseases; D008875:Middle Aged; D011044:Poland / Q000453:epidemiology; D015995:Prevalence; D012747:Sexual Partners; D014141:Trachoma / Q000453:epidemiology*
D007074:Immunoglobulin G